Report segments information on Global Non-Steroidal Anti-Inflammatory Drugs Market By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.
Global Non-Steroidal Anti-Inflammatory Drugs Key Companies Studied In Report are:
- GlaxoSmithKline plc
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Zyla Life Sciences
- Horizon Therapeutics plc.
An Overview of the Impact of COVID-19 on Non-Steroidal Anti-Inflammatory Drugs Market:
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future. The coronavirus incident has caused major damage to all the industries across the globe. The governments of several countries have instigated lockdown to thwart the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain.
Global Non-steroidal Anti-Inflammatory Drugs Market Analysis 2020:
Chronic pain causes a major health and economic burden owing to the loss of productivity and treatment cost. Non-steroidal anti-inflammatory drugs are primarily used for the treatment of pain and inflammation. The rising prevalence of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, migraine, and others is increasing the uptake of these drugs. With the increasing number of prescriptions, these have become the most commonly used drugs across the globe. According to a press release of Endo International plc, about 84 million NSAIDs prescriptions are written annually in the U.S.
The global Non-steroidal Anti-Inflammatory Drugs market is projected to witness rapid growth in the coming years driven by the massive investments in product RandD. The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global Non-steroidal Anti-Inflammatory Drugs market and discusses how major companies are coping with this.
The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Non-steroidal Anti-Inflammatory Drugs Market Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
Non-steroidal Anti-Inflammatory Drugs Market Regional Insights:
Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.